Skip to main content Back to Top
Advertisement

1/15/2023

Prednisone Oral Tablets

Products Affected - Description

    • Prednisone oral tablet, Hikma, 10 mg, bottle, 100 count, NDC 00054-0017-25
    • Prednisone oral tablet, Hikma, 10 mg, bottle, 500 count, NDC 00054-0017-29
    • Prednisone oral tablet, Hikma, 2.5 mg, unit-dose blister pack, 100 count, NDC 00054-8740-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 100 count, NDC 00054-0018-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 500 count, NDC 00054-0018-29
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 1000 count, NDC 00054-4728-31
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 48 count, NDC 00591-5442-43
    • Prednisone oral tablet, Teva, 5 mg, bottle, 100 count, NDC 00591-5052-01
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 21 count, NDC 00591-5052-21
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 48 count, NDC 00591-5052-43

Reason for the Shortage

    • Cadista has all prednisone tablet presentations available.
    • Hikma is allocating prednisone tablets to ensure all customers get adequate supply during COVID-19.
    • Par has prednisone tablets available.
    • Teva did not provide a reason for the shortage.

Available Products

    • Prednisone oral tablet, Cadista, 1 mg, bottle, 100 count, NDC 59746-0171-06
    • Prednisone oral tablet, Cadista, 1 mg, bottle, 1000 count, NDC 59746-0171-10
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 100 count, NDC 59746-0173-06
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 1000 count, NDC 59746-0173-10
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 100 count, NDC 59746-0175-06
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 500 count, NDC 59746-0175-09
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 100 count, NDC 59746-0172-06
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 1000 count, NDC 59746-0172-10
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 100 count, NDC 00054-4741-25
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 1000 count, NDC 00054-4741-31
    • Prednisone oral tablet, Hikma, 1 mg, unit-dose blister pack, 100 count, NDC 00054-8739-25
    • Prednisone oral tablet, Hikma, 10 mg, unit-dose blister pack, 100 count, NDC 00054-0017-20
    • Prednisone oral tablet, Hikma, 2.5 mg, bottle, 100 count, NDC 00054-4742-25
    • Prednisone oral tablet, Hikma, 20 mg, unit-dose blister pack, 100 count, NDC 00054-0018-20
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 100 count, NDC 00054-4728-25
    • Prednisone oral tablet, Hikma, 5 mg, unit-dose blister pack, 100 count, NDC 00054-8724-25
    • Prednisone oral tablet, Hikma, 50 mg, bottle, 100 count, NDC 00054-0019-25
    • Prednisone oral tablet, Hikma, 50 mg, unit-dose blister pack, 100 count, NDC 00054-0019-20
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 100 count, NDC 00603-5335-21
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 1000 count, NDC 00603-5335-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 100 count, NDC 00603-5338-21
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 500 count, NDC 00603-5338-28
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 00603-5338-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 21 count, NDC 00603-5338-15
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 48 count, NDC 00603-5338-31
    • Prednisone oral tablet, Par Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 00603-5336-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 100 count, NDC 00603-5339-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 500 count, NDC 00603-5339-28
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 00603-5339-32
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 100 count, NDC 00603-5337-21
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 00603-5337-32
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 21 count, NDC 00603-5337-15
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 48 count, NDC 00603-5337-31
    • Prednisone oral tablet, Teva, 10 mg, bottle, 100 count, NDC 00591-5442-01
    • Prednisone oral tablet, Teva, 10 mg, bottle, 500 count, NDC 00591-5442-05
    • Prednisone oral tablet, Teva, 10 mg, bottle, 1000 count, NDC 00591-5442-10
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 21 count, NDC 00591-5442-21
    • Prednisone oral tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-5443-01
    • Prednisone oral tablet, Teva, 20 mg, bottle, 500 count, NDC 00591-5443-05
    • Prednisone oral tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-5443-10
    • Prednisone oral tablet, Teva, 5 mg, bottle, 1000 count, NDC 00591-5052-10

Estimated Resupply Dates

    • Hikma has prednisone 2.5 mg tablets in unit-dose packages, 5 mg tablets in 1,000-count bottles, 10 mg tablets in 100-count and 500-count bottles, and 20 mg tablets in 100-count and 500-count bottles on allocation.
    • Teva has prednisone 5 mg tablets in 21-count and 48-count blister packs, 5 mg tablets in 100-count bottles, and 10 mg tablets in 48-count blister packs on back order and the company estimates a release date of mid-to-late-January 2023 for the 5 mg in 21-count and 48-count blister packs, mid-February for the 5 mg tablets in 100-count bottles, and late-January to early-February 2023 for the 10 mg tablets in 48-count blister packs.

Updated

Updated January 15, 2023 by Elyse MacDonald, PharmD, MS, BCPS. Created May 15, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.